Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

xii
Editors
the United States Food and Drug Administration (FDA) in 2010 as an Oak Ridge
Institute for Science and Education (ORISE) fellow. Beginning in December
2011, Dr. Xie became full professor of pharmacology and mentor of PhD students
at Nanjing Medical University (Nanjing, China), and was appointed chief of the
General Clinical Research Center, Nanjing First Hospital. In 2014, Dr. Xie was
awarded the Distinguished Medical Expert of Jiangsu Province, China.
Dr. Xie is active in the research field of clinical pharmacology— pharmacogenomics
and personalized medicine, in particular—with at least 130 papers published,
many in leading journals worldwide, including New England Journal of Medicine,
Annual Review of Pharmacology and Toxicology, Advanced Drug Delivery
Reviews, Pharmacology & Therapeutics, Clinical Pharmacology & Therapeutics,
Drug Metabolism Reviews, The Pharmacogenomics Journal, Pharmacogenomics,
Pharmacogenetics & Genomics, Journal of Thrombosis & Haemostasis, Drug
Metabolism and Disposition, and Personalized Medicine. In addition, he has
authored several chapters in books published by Springer, Wiley, ASM Press, and
Annual Reviews. Dr. Xie has served on the editorial board of Pharmacogenomics,
UK (2003–2011); American Journal of PharmacoGenomics (currently Molecular
Diagnosis & Therapy), New Zealand; and Journal of Geriatric Cardiology, China.
Dr. Xie has also been invited to review about 30 scientific journals in the United States
and the United Kingdom as well as other countries. More recently, Dr. Xie was invited
to edit the English textbook Pharmacology for the medical students nationwide as an
associate editor-in-chief, which will be published by the People’s Medical Publishing
House, Beijing, China.